首页> 外文期刊>Biomedical Research >Plasma miR-124 as a biomarker for cerebral infarction
【24h】

Plasma miR-124 as a biomarker for cerebral infarction

机译:血浆miR-124作为脑梗死的生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are endogenous small RNAs that play an important role in various physiological processes by downregulating target genes. Recently, plasma miRNAs have been investigated as biomarkers for various diseases. In this study, miRNA array analysis in various tissues showed that miR-124 is almost exclusively expressed in the central nervous system and neuronal cells, suggesting that it might be useful as a potential biomarker for neurological diseases. We examined whether plasma concentrations of brain-specific miRNA can serve as a biomarker for cerebral infarction, where the cerebral infarction was modeled by middle cerebral artery occlusion (MCAO) in the rat. Plasma concentrations of miR-124 were significantly elevated at 6 h, and remained elevated at 48 h after MCAO introduction. Thus, plasma concentration of miR-124 provides a promising candidate biomarker for early detection of cerebral infarction.
机译:MicroRNA(miRNA)是内源性小RNA,通过下调靶基因在各种生理过程中发挥重要作用。近来,已经研究了血浆miRNA作为各种疾病的生物标记。在这项研究中,在各种组织中进行的miRNA阵列分析表明,miR-124几乎仅在中枢神经系统和神经元细胞中表达,这表明它可能用作神经系统疾病的潜在生物标记。我们检查了血浆中特定于大脑的miRNA的浓度是否可以作为脑梗死的生物标记物,其中脑梗死是通过大鼠中脑动脉闭塞(MCAO)建模的。在MCAO引入后,miR-124的血浆浓度在6 h时显着升高,并在48 h时保持升高。因此,miR-124的血浆浓度为早期检测脑梗死提供了有希望的候选生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号